[
  {
    "ts": null,
    "headline": "Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors",
    "summary": "It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...",
    "url": "https://finnhub.io/api/news?id=f1507fb38034c7612091962e03ee959be1469372ae082edbbbd4d61500dc793c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771164018,
      "headline": "Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors",
      "id": 139107019,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...",
      "url": "https://finnhub.io/api/news?id=f1507fb38034c7612091962e03ee959be1469372ae082edbbbd4d61500dc793c"
    }
  },
  {
    "ts": null,
    "headline": "IDEXX Laboratories Inc. (IDXX) Shows Resilience as Analysts Reassess Targets",
    "summary": "IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the best medical technology stocks to invest in. On February 3, BTIG lowered its price target on IDEXX Laboratories Inc. (NASDAQ:IDXX) to $800 from $830 and maintained a Buy rating. The firm cited concerns about IDEXX’s 2026 guidance despite robust Q4 2025 earnings performance. IDEXX reported strong fourth-quarter […]",
    "url": "https://finnhub.io/api/news?id=9974daf79d94705b4856727a89da15b1ca6fea41812cc09936db9ab9adfd6fc6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771156413,
      "headline": "IDEXX Laboratories Inc. (IDXX) Shows Resilience as Analysts Reassess Targets",
      "id": 139105977,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "IDXX",
      "source": "Yahoo",
      "summary": "IDEXX Laboratories Inc. (NASDAQ:IDXX) is one of the best medical technology stocks to invest in. On February 3, BTIG lowered its price target on IDEXX Laboratories Inc. (NASDAQ:IDXX) to $800 from $830 and maintained a Buy rating. The firm cited concerns about IDEXX’s 2026 guidance despite robust Q4 2025 earnings performance. IDEXX reported strong fourth-quarter […]",
      "url": "https://finnhub.io/api/news?id=9974daf79d94705b4856727a89da15b1ca6fea41812cc09936db9ab9adfd6fc6"
    }
  }
]